| Literature DB >> 18278811 |
Robert G Uzzo1, Naomi B Haas, Paul L Crispen, Vladimir M Kolenko.
Abstract
New therapeutic strategies are needed to improve treatment outcomes in men with hormone-refractory prostate cancer. A better understanding of the molecular mechanisms of cell death in response to therapeutic strategies will help avoid ineffective treatment regimens and provide a molecular basis for new therapeutic modalities targeting apoptosis-resistant forms of prostate cancer. In this review, the authors focused on the established aberrations of apoptosis in hormone-refractory prostate cancer, and they have described novel treatment strategies to overcome apoptosis resistance.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18278811 DOI: 10.1002/cncr.23318
Source DB: PubMed Journal: Cancer ISSN: 0008-543X Impact factor: 6.860